Stroma Biology Identifies Heparin as a Differentiating Agent in Neuroblastoma
|
Duke University Medical Center / Gerard Blobe, MD, PhD |
Reach Grants |
2013 |
North Carolina |
Dissecting the Hierarchy of Tumor Cell Differentiation Using Dual Recombinase Technology in a Novel Mouse Model of Rhabdomyosarcoma |
Duke University Medical Center / David Van Mater, MD, PhD |
Young Investigator Grants |
2013 |
North Carolina |
Function of the PR Domain of the MDSI-EVI1 in MLL Fusion Protein Leukemogenesis |
University of Rochester / Archibald Perkins, MD, PhD |
Springboard Grants |
2013 |
New York |
Columbia University Developmental Therapeutics Program: Striving for Excellence
|
Columbia University / Julia Glade Bender, MD |
Phase I/II Infrastructure Grants |
2013 |
New York |
Identification of TFAP4 (Transcription Factor AP-4/Activating Enhancer Binding Protein) as a Potential Master Regulator/Synthetic Lethal Gene of MYCN Amplified Neuroblastoma |
Columbia University Medical Center / Darrell Yamashiro, MD, PhD |
Innovation Grants |
2013 |
New York |
Epigenomics of High Risk Pediatric T Cell Leukemia |
New York University School of Medicine / Iannis Aifantis, PhD |
Reach Grants |
2013 |
New York |
Rational Combination Therapy of AML |
Memorial Sloan-Kettering Cancer Center / Alex Kentsis, MD, PhD |
'A' Award Grants |
2013 |
New York |
Therapeutic Targeting of LARG-RhoA Signaling Axis in Childhood Leukemia |
Cincinnati Children's Hospital Medical Center / Yi Zheng, PhD |
Innovation Grants |
2013 |
Ohio |
The Phase I/II Trials Collaborative for Children, Adolescents, and Young Adults at UH Rainbow Babies & Children's Hospital and the Case Comprehensive Cancer Center |
Case Western Reserve University / Letterio, John MD & Matloub, Yousif MD |
Phase I/II Infrastructure Grants |
2013 |
Ohio |
Development of MicroRNA-Nanoparticles to Treat Childhood Acute Leukemia Carrying MLL Rearrangements |
University of Cincinnati College of Medicine / Jianjun Chen, PhD |
Innovation Grants |
2013 |
Ohio |